Your browser doesn't support javascript.
loading
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy, Michael A; Santos, Stephanie; Kerkhof, Jennifer; Stuart, Alan; Aref-Eshghi, Erfan; Guo, Fen; Hedley, Ben; Wong, Henry; Rauh, Michael; Feilotter, Harriet; Berardi, Philip; Semenuk, Laura; Yang, Ping; Knoll, Joan; Ainsworth, Peter; McLachlin, Catherine Meg; Chin-Yee, Ian; Kovacs, Michael; Deotare, Uday; Lazo-Langner, Alejandro; Hsia, Cyrus; Keeney, Mike; Xenocostas, Anargyros; Howlett, Christopher; Lin, Hanxin; Sadikovic, Bekim.
Afiliación
  • Levy MA; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Santos S; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Kerkhof J; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Stuart A; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Aref-Eshghi E; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Guo F; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Hedley B; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Wong H; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Rauh M; Pathology and Laboratory Medicine, London Health Sciences Centre, London, Ontario, Canada.
  • Feilotter H; Clinical Laboratories, Kingston Health Sciences Centre, Kingston, Ontario, Canada.
  • Berardi P; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
  • Semenuk L; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
  • Yang P; Molecular Diagnostics, Kingston Health Sciences Centre, Kingston, Ontario, Canada.
  • Knoll J; University of Ottawa, Ottawa, Ontario, Canada.
  • Ainsworth P; Eastern Ontario Regional Laboratory Association (EORLA), The Ottawa Hospital, Ottawa, Ontario, Canada.
  • McLachlin CM; DNA Diagnostics & Cytogenetics Laboratory, Kingston Health Sciences Centre, Kingston, Ontario, Canada.
  • Chin-Yee I; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Kovacs M; Cytogenetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Deotare U; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Lazo-Langner A; Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Hsia C; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Keeney M; Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, Ontario, Canada.
  • Xenocostas A; Department of Biochemistry, Western University, London, Ontario, Canada.
  • Howlett C; Department of Pathology, London Health Sciences Centre, London, Ontario, Canada.
  • Lin H; Hematology Division, London Health Sciences Centre, London, Ontario, Canada.
  • Sadikovic B; Hematology Division, London Health Sciences Centre, London, Ontario, Canada.
Eur J Haematol ; 103(3): 178-189, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31177553

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Biomarcadores de Tumor / Proteínas de Fusión Oncogénica / Neoplasias Hematológicas / Secuenciación de Nucleótidos de Alto Rendimiento Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Biomarcadores de Tumor / Proteínas de Fusión Oncogénica / Neoplasias Hematológicas / Secuenciación de Nucleótidos de Alto Rendimiento Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá
...